Bosque M, Munian A, Bewick M, Haycock G, Chantler C
Arch Dis Child. 1983 Feb;58(2):110-4. doi: 10.1136/adc.58.2.110.
The growth of every child with a bone age less than 15 years who received a first renal transplant between 1975 and 1980 was analysed to determine the growth expectation of children with renal transplants substantially maintained on alternate-day prednisolone. Growth was expressed as a standard deviation score defined as the difference between the standard deviation for height at the time of the transplant and at the end of 1981. Average growth achieved by the 46 children. 41 with functioning transplants, was normal with a mean standard deviation score of +0.7 +/- 0.3 (SEM) for boys and -0.3 +/- 0.3 (SEM) for girls; 25 of the children had accelerated growth. Mean standard deviation scores per year of advance of bone age in 29 children was +0.003, which suggested no overall loss of growth potential. No difference in growth per year of advance in bone age was detected in children with a bone age less than 12 years at transplant compared with more mature children, but boys with a bone age less than 12 years grew better per year of advance in chronological age; this appeared to be related at least in part to their greater growth deficit at transplant. Glomerular filtration rate, alternate-day prednisolone dose, and level of plasma phosphate did not appear to affect growth in the 11 prepubertal children with functioning first grafts.
对1975年至1980年间接受首次肾移植且骨龄小于15岁的每个儿童的生长情况进行了分析,以确定基本上隔日服用泼尼松龙的肾移植儿童的生长预期。生长情况用标准差评分表示,定义为移植时身高标准差与1981年底身高标准差之间的差值。46名儿童(41名移植肾功能正常)的平均生长情况正常,男孩的平均标准差评分为+0.7±0.3(标准误),女孩为-0.3±0.3(标准误);其中25名儿童生长加速。29名儿童骨龄每年提前的平均标准差评分为+0.003,这表明总体生长潜力没有丧失。与骨龄较大的儿童相比,移植时骨龄小于12岁的儿童骨龄每年提前的生长情况没有差异,但骨龄小于12岁的男孩按实际年龄每年提前的生长情况更好;这似乎至少部分与他们在移植时更大的生长缺陷有关。肾小球滤过率、隔日泼尼松龙剂量和血浆磷酸盐水平似乎对11名首次移植肾功能正常的青春期前儿童的生长没有影响。